Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Hydroxide Formulations for Postoperative Pain in Necrotic Pulp
NCT05021809Phase 4Unknown
- Sponsor
- Suez Canal University
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of calcium hydroxide, Iodoform in pulp necrosis, apical periodontitis (AP), sponsored by Suez Canal University. Status: unknown.
02
Drugs
calcium hydroxideIodoform
03
Conditions
pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT05021809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021809.